GlassScriptPrepare for your visit
Christopher Bachuss
Family · Nashville, TN · NPI 1437147626
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$13,382.52
in general payments reported to CMS, 2019-2025 · $2,784 in 2025
The $2,784 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $1,678.20
- Biogen, INC. $782.53
- Ucb, INC. $756.69
- Emd Serono, INC. $754.77
- Neurocrine Biosciences, INC. $714.94
- Lilly USA, LLC $659.37
Drugs and devices associated with these payments
Ubrelvy Qulipta Briumvi Austedo Xr Nuplazid Vumerity Ingrezza Ultomiris Rexulti Kisunla Vyepti Kesimpta
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Christopher Bachuss listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11115091/christopher-bachuss